In Vitro Characterization of Vilazodone as a Dual-Acting Serotonin Reuptake Inhibitor and 5-HT1A Receptor Partial Agonist

被引：0
|
作者：
Kehne, John H. [1 ]
Bartoszyk, Gerd D. [2 ]
Greiner, Hartmut E. [2 ]
Pierz, Kerri A. [3 ]
Renda, Matthew J. [3 ]
van Amsterdam, Christoph [2 ]
Reed, Carol R. [3 ]
Athanasiou, Maria C. [3 ]
机构：
[1] Translat Neuropharmacol Consulting LLC, Execut, Rockville, MD USA
[2] Merck KGaA, Preclin Pharmaceut Res, Darmstadt, Germany
[3] PGxHealth LLC, Div Clin Data, Med Affairs, New Haven, CT USA
来源：
BIOLOGICAL PSYCHIATRY | 2010年 / 67卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
821
引用
收藏
页码：237S / 237S
页数：1
相关论文
共 50 条
  • [11] Vilazodone, a Selective Serotonin Reuptake Inhibitor with Diminished Impact on Methylphenidate-Induced Gene Regulation in the Striatum: Role of 5-HT1A Receptor
    Michael Hrabak
    Connor Moon
    Carlos A. Bolaños-Guzmán
    Heinz Steiner
    Molecular Neurobiology, 2024, 61 : 1907 - 1919
  • [12] Vilazodone, a Selective Serotonin Reuptake Inhibitor with Diminished Impact on Methylphenidate-Induced Gene Regulation in the Striatum: Role of 5-HT1A Receptor
    Hrabak, Michael
    Moon, Connor
    Bolanos-Guzman, Carlos A.
    Steiner, Heinz
    MOLECULAR NEUROBIOLOGY, 2024, 61 (04) : 1907 - 1919
  • [13] Population Pharmacokinetics of the Selective Serotonin 5-HT1A Receptor Partial Agonist Piclozotan
    Mondick, John I.
    Oo, Charles
    Patel, Dimple
    Fujitani, Tomomichi
    Shimizu, Kahori
    Barrett, Jeffrey S.
    AMERICAN JOURNAL OF THERAPEUTICS, 2009, 16 (02) : 106 - 115
  • [14] Involvement of 5-HT1A Receptor in the Inhibition of selective serotonin reuptake inhibitor and serotonin noradrenaline reuptake inhibitor on marble-burying behavior
    Matsushita, M.
    Egashira, N.
    Okuno, R.
    Chidori, S.
    Uchida, N.
    Mishima, K.
    Iwasaki, K.
    Nishimura, R.
    Fujiwara, M.
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2007, 61 (02) : S7 - S7
  • [15] Modulation of Serotonergic Function in Rat Brain by VN2222, a Serotonin Reuptake Inhibitor and 5-HT1A Receptor Agonist
    Luz Romero
    Pau Celada
    Raúl Martín-Ruiz
    Llorenç Díaz-Mataix
    Marisabel Mourelle
    Joaquim Delgadillo
    Ildefonso Hervás
    Francesc Artigas
    Neuropsychopharmacology, 2003, 28 : 445 - 456
  • [16] Vilazodone: a brief pharmacological and clinical review of the novel serotonin partial agonist and reuptake inhibitor
    Schwartz, Thomas L.
    Siddiqui, Umar A.
    Stahl, Stephen M.
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2011, 1 (03) : 81 - 87
  • [17] Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of Rat Prefrontal Cortical Dopamine Response to Dual Acting Norepinephrine Reuptake Inhibitor and 5-HT1A Partial Agonist
    Li, Cheryl Shuang-wu
    Zhang, Liming
    Haske, Taraneh
    Dounay, Amy
    Gray, David
    Barta, Nancy
    Brodfuehrer, Joanne
    Lepsy, Christopher
    Campbell, Brian
    AAPS JOURNAL, 2012, 14 (02): : 365 - 376
  • [18] Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of Rat Prefrontal Cortical Dopamine Response to Dual Acting Norepinephrine Reuptake Inhibitor and 5-HT1A Partial Agonist
    Cheryl Shuang-wu Li
    Liming Zhang
    Taraneh Haske
    Amy Dounay
    David Gray
    Nancy Barta
    Joanne Brodfuehrer
    Christopher Lepsy
    Brian Campbell
    The AAPS Journal, 2012, 14 : 365 - 376
  • [19] EMD 68843, a serotonin reuptake inhibitor with selective presynaptic 5-HT1A receptor agonistic properties
    Bartoszyk, GD
    Hegenbart, R
    Ziegler, H
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 322 (2-3) : 147 - 153
  • [20] Drug evaluation:: Vilazodone -: a combined SSRI and 5-HT1A partial agonist for the treatment of depression
    de Paulis, Tomas
    IDRUGS, 2007, 10 (03) : 193 - 201
12345